ClearPoint Neuro Inc vs Toyota Motor Corp — how do they compare? ClearPoint Neuro Inc trades at $15.7 (market cap $478.63M), while Toyota Motor Corp trades at $176.77 (market cap $205.39B). The key difference: Toyota Motor Corp is far larger — about 429.1× ClearPoint Neuro Inc's market cap, and Toyota Motor Corp pays a 3.59% dividend while ClearPoint Neuro Inc pays none. Which is the better fit depends on your goals.
| CLPT | TM | |
|---|---|---|
Market Cap | $478.63M | $205.39B |
Sector | Health | Consumer Cyclical |
52-Week High | $29.60 | $248.29 |
52-Week Low | $8.66 | $166.50 |
Enterprise Value | $506.63M | $369.58B |
Dividend Yield | — | 3.59% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Toyota Motor trades at $174.75, down 0.96% with neutral technical signals. The stock shows attractive valuation metrics including a P/E of 9.58 and P/B of 0.84, trading below industry averages. Recent earnings have consistently beaten expectations, with Q1 2026 EPS of $4.00 exceeding the $3.11 estimate. The company's $3.6 billion Texas expansion signals strong growth commitment amid positive hybrid vehicle sales momentum.
Toyota presents a compelling value opportunity with strong fundamentals and consistent earnings performance. However, declining profit margins and increasing debt levels warrant monitoring. Analyst consensus leans neutral with 62.5% hold ratings, suggesting cautious optimism about the company's strategic investments and hybrid leadership position in the evolving automotive landscape.
Trailing returns across standard periods
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →Founded in 1937, Toyota is one of the world's largest automakers with 10.38 million units sold at retail in fiscal 2022 across its light vehicle brands. Brands include Toyota, Lexus, Daihatsu, and truck maker Hino.
Read more on TM →